Veraxa Biotech Holding AG (VRXA) Liabilities and Shareholders Equity (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Liabilities and Shareholders Equity of $101.1 million for Q4 2025, up 4.5% year-over-year from $96.8 million in Q4 2024, and up 4.5% quarter-over-quarter from $96.8 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Liabilities and Shareholders Equity for 2 consecutive years, with $101.1 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.12 Mn |
| Dec 31, 2024 | 96.76 Mn |